Research and development of oligonucleotide drug delivery platforms for use in the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for targeted gene silencing

'compound':24,44 'deliveri':7 'develop':3,21,41 'diseas':16,36 'disord':18,38 'drug':6 'gene':47 'genet':15,35 'oligonucleotid':5,23,43 'pharmaceut':29 'platform':8 'research':1,19,39 'silenc':48 'target':28,46 'therapi':30 'treatment':13,33 'use':10,26

PRISM

Owners

Goods & Services